Weili Huang

Weili Huang is a DMPK/Clinical Pharmacology Consultant at Aclairo Pharmaceutical Development Group, where she has been contributing her expertise since January 2022. With over 20 years of experience in pharmaceutical and regulatory sciences, Dr. Huang has a robust background in clinical pharmacology and drug metabolism and pharmacokinetics (DMPK) .12

Education and Early Career

Dr. Huang earned her Ph.D. in Pharmaceutics from the University of Washington in 2006. Following her academic achievements, she began her career as a pharmacologist reviewer at the FDA's Center for Drug Evaluation and Research (CDER) .12

Professional Experience

Before joining Aclairo, she worked as an independent consultant, providing strategic guidance on drug discovery and development projects for various pharmaceutical companies. Her role involves overseeing nonclinical and clinical development processes, drafting regulatory submissions, and reviewing bioanalytical reports .23

Areas of Expertise

Dr. Huang specializes in:

• Clinical Pharmacology
• DMPK (Drug Absorption, Metabolism, Drug Transport, Drug-Drug Interactions)
• Regulatory strategies for Investigational New Drug (IND) and New Drug Application (NDA) submissions .12

In addition to her consulting work, Dr. Huang has been involved in AI projects related to drug discovery and development, providing training seminars on cutting-edge themes in the field .2